Results summary | View all lists in GO:BiolProc | View all genes in C05AA.profile.ud50 |
regulation of biological process Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule. enrichment: 1.33-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
214786_AT | MAP3K1 | G | X | P | S | mitogen-activated protein kinase kinase kinase 1 | |||||||
218502_S_AT | TRPS1 | T | D | R | trichorhinophalangeal syndrome I | ||||||||
215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
219657_S_AT | KLF3 | D | R | Kruppel-like factor 3 (basic) | |||||||||
205440_S_AT | NPY1R | E | S | neuropeptide Y receptor Y1 | |||||||||
213668_S_AT | SOX4 | R | SRY (sex determining region Y)-box 4 | ||||||||||
213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
202861_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
213552_AT | GLCE | E | P | glucuronic acid epimerase | |||||||||
204526_S_AT | TBC1D8 | G | S | TBC1 domain family, member 8 (with GRAM domain) | |||||||||
214439_X_AT | BIN1 | G | T | D | bridging integrator 1 | ||||||||
217427_S_AT | HIRA | D | R | HIR histone cell cycle regulation defective homolog A (S. cerevisiae) | |||||||||
215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
203358_S_AT | EZH2 | D | P | R | enhancer of zeste homolog 2 (Drosophila) | ||||||||
203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
209304_X_AT | GADD45B | G | D | X | S | growth arrest and DNA-damage-inducible, beta | |||||||
207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
203542_S_AT | KLF9 | D | R | S | Kruppel-like factor 9 | ||||||||
212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
36829_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
201945_AT | FURIN | P | C | furin (paired basic amino acid cleaving enzyme) | |||||||||
200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
221009_S_AT | ANGPTL4 | G | D | X | E | S | angiopoietin-like 4 | ||||||
205409_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
201418_S_AT | SOX4 | R | SRY (sex determining region Y)-box 4 | ||||||||||
208960_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 | ||||||||
202725_AT | POLR2A | R | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | ||||||||||
37152_AT | PPARD | G | T | D | E | R | C | S | peroxisome proliferator-activated receptor delta | ||||
208937_S_AT | ID1 | D | R | S | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||||
205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
211833_S_AT | BAX | G | T | D | X | P | S | BCL2-associated X protein |